The bacterial signaling molecule cyclic di-GMP (c-di-GMP) stimulates the synthesis of bacterial cellulose, which is frequently found in biofilms. Bacterial cellulose is synthesized and translocated across the inner membrane by a complex of cellulose synthase BcsA and BcsB subunits. Here we present crystal structures of the c-di-GMP-activated BcsA-BcsB complex. The structures reveal that c-di-GMP releases an autoinhibited state of the enzyme by breaking a salt bridge that otherwise tethers a conserved gating loop that controls access to and substrate coordination at the active site. Disrupting the salt bridge by mutagenesis generates a constitutively active cellulose synthase. Additionally, the c-di-GMP-activated BcsA-BcsB complex contains a nascent cellulose polymer whose terminal glucose unit rests at a new location above BcsA's active site and is positioned for catalysis. Our mechanistic insights indicate how c-di-GMP allosterically modulates enzymatic functions.
a r t i c l e s
Biofilms are sessile multicellular bacterial communities that are encased in a three-dimensional meshwork of biopolymers, such as polysaccharides, proteinaceous filaments and nucleic acids [1] [2] [3] . The biofilm matrix provides protection against mechanical stress and controls the diffusion of signaling molecules, nutrients and toxic compounds 4, 5 . In fact, biofilm communities exhibit increased tolerance toward conventional antimicrobial treatments and sterilization techniques, and they are responsible for many chronic infections such as those associated with cystic fibrosis and endocarditis 6, 7 as well as nosocomial infections 8 . In many cases, biofilm formation occurs in response to an elevated cytosolic concentration of c-di-GMP 9 , a bacterial signaling molecule recognized by a wide range of effectors, including transcription factors, flagellar components, riboswitches and exopolysaccharide synthases 1 . Therefore, targeting c-di-GMPbinding effectors has emerged as an attractive new route for the development of urgently needed new antimicrobial therapeutics.
C-di-GMP activates the synthesis of bacterial cellulose 1, 10 , an extracellular polysaccharide often found in biofilms 11 . C-di-GMP monomers and dimers 12, 13 are both recognized by effector proteins via PilZ domains, first identified as regulatory components of cell motility 14 , which contain an RXXXR motif (in which X represents any amino acid) in a flexible linker region followed by a β-sheet or β-barrel that contains a DXSXXG motif 15 . Both sequence motifs have been shown to interact with c-di-GMP in structures of isolated PilZ domains 16, 17 . However, the mechanism by which c-di-GMP binding at PilZ domains modulates enzymatic functions is completely unknown to date.
Extracellular polysaccharides of the biofilm matrix, such as cellulose, alginate and poly-N-acetylglucosamine (PNAG), are probably synthesized and secreted by a conserved mechanism [18] [19] [20] [21] [22] . Bacterial cellulose synthase polymerizes glucose molecules via β-1,4 glycosidic linkages in a multistep process that requires the presence of a divalent cation, usually magnesium 23 . First, upon stimulation by c-di-GMP, the enzyme binds its substrate UDP-glucose (UDP-Glc, referred to here as the 'donor') at an intracellular glycosyltransferase (GT) domain. Second, the donor glucose is transferred to the 4′-OH group at the nonreducing end of the growing polysaccharide chain (the 'acceptor'), thereby extending the polymer and forming UDP as a second reaction product 23, 24 . Third, after glycosyl transfer, the elongated polymer has to be translocated by one glucose unit into a transmembrane (TM) channel so that the newly added glucose unit occupies the acceptor site, and UDP must be replaced with UDP-Glc for another round of catalysis.
The membrane-integrated bacterial cellulose synthase contains the inner-membrane components BcsA and BcsB as well as the outermembrane protein BcsC 25, 26 . BcsA, together with the periplasmic membrane-anchored BcsB subunit, forms a complex that is sufficient for cellulose synthesis and translocation 23, 27 . BcsA is homologous to eukaryotic cellulose synthases 28 and contains eight TM helices and a cytosolic GT domain between TM helices four and five 27 . The enzyme is a processive family 2 GT 29 that elongates the nonreducing end of the growing polysaccharide chain. This reaction requires a general base, which is probably provided by the aspartate residue of a TED motif found at the beginning of a short helix within the GT domain and in proximity to the acceptor's 4′-OH 27 . BcsA also forms a polysaccharide channel across the membrane, directly above the active site, thereby allowing the coupling of cellulose synthesis and translocation 27, 30 .
Bacterial cellulose and alginate synthases are activated by c-di-GMP via PilZ domains 15, 31 . BcsA forms a PilZ domain within its C-terminal intracellular extension, which consists of a six-stranded β-barrel and a preceding linker region 15, 27 . The β-barrel rests against the intracellular GT domain and is connected to BcsA's C-terminal TM helix a r t i c l e s (TM8) via a linker (TM8-β-barrel linker) containing the RXXXR motif involved in c-di-GMP binding 15 .
The TM8-β-barrel linker also interacts with BcsA's gating loop, which runs across the opening of the GT domain toward the cytosol, thereby blocking access to the catalytic pocket in the nonstimulated or 'resting' state of the enzyme 27 . It was speculated that substrate binding to the active site requires the repositioning of the gating loop, perhaps induced by c-di-GMP 27 . This model is supported by biochemical studies indicating that increasing c-di-GMP concentrations do not alter K m for UDPGlc but instead increase the fraction of catalytically active enzymes 23 .
In order to unravel the mechanism by which c-di-GMP activates bacterial cellulose synthase, we determined c-di-GMP-bound structures of the Rhodobacter sphaeroides BcsA-BcsB complex at intermediate states during cellulose synthesis and translocation. The c-di-GMP-bound structures reveal the architecture of the activated BcsA-BcsB complex and provide unique insights into the mechanism of c-di-GMP signaling. These include the identification of a conserved regulatory salt bridge that autoinhibits BcsA in the absence of c-di-GMP and of UDP-dependent repositioning of the gating loop to either open the catalytic pocket or coordinate the nucleotide at the active site. Furthermore, the structures reveal the movement of a 'finger helix' of BcsA, which interacts with the acceptor end of the translocating cellulose polymer, toward the TM-channel entrance, thus correlating with the translocation of the cellulose polymer into the channel by one glucose unit. Our data provide the first insights, to our knowledge, into the mechanism by which c-di-GMP modulates enzymatic functions and represent new snapshots of cellulose synthesis and membrane translocation.
RESULTS

Architecture of BcsA-BcsB in complex with c-di-GMP
We purified R. sphaeroides BcsA-BcsB from Escherichia coli, crystallized it in complex with c-di-GMP by the bicelle crystallization method 32, 33 and solved the structure, by molecular replacement, at a resolution of 2.65 Å. Additionally, we obtained a c-di-GMP-and UDP-bound structure of BcsA-BcsB by soaking crystals with UDP and refining at 3.2-Å resolution ( Table 1) . Both structures contain a translocating cellulose polymer of 17 glucose units that copurifies with the BcsA-BcsB complex.
Overall, the c-di-GMP-bound BcsA-BcsB structure is consistent with the previously reported structure obtained from detergentsolubilized complexes (r.m.s. deviation ≈1 Å for all atoms) 27 (Fig. 1) . We identified two register shifts by one residue in regions that were poorly ordered in the previously reported structure of BcsA (residues 171-190) and BcsB (residues 268-280). The corrected register in BcsA positions Asp179 of the DDG motif within hydrogen-bonding distance of the conserved Tyr216 and also positions Asp180 within hydrogen-bonding distance of the uracil moiety of UDP and Arg219 (Supplementary Fig. 1 ).
BcsA binds a c-di-GMP dimer on the b-barrel surface
BcsA's C-terminal PilZ domain binds an intercalated c-di-GMP dimer 12 ( Fig. 1 and Supplementary Fig. 2 ). The guanine groups of the c-di-GMP dimer stack in parallel to the β-barrel surface and perpendicularly to the TM8-β-barrel linker. One c-di-GMP molecule (c-di-GMP-A) interacts with the DXSXXG motif on the β-barrel surface, whereas the second (c-di-GMP-B) is stabilized by π-π stacking interactions with c-di-GMP-A as well as by residues within the TM8-β-barrel linker (Fig. 1c) .
All of the conserved PilZ-domain residues mediate interactions with the c-di-GMP dimer (Supplementary Fig. 2b ), as has also been observed with isolated PilZ domains 16, 17 . Of note is the interaction of the RXXXR motif within the TM8-β-barrel linker with c-di-GMP (Fig. 1c) . The N-terminal arginine of this motif (Arg580) runs coplanar to the second guanylate of c-di-GMP-A and forms hydrogen bonds via its guanidinium group with the guanine's N7 and carbonyl oxygen. The C-terminal arginine (Arg584) of the RXXXR motif also interacts with c-di-GMP-A by stacking on top of the first guanylate and forming a salt bridge with the phosphate group of the second ( Fig. 1c and Supplementary Fig. 2b ). In the absence of c-di-GMP, Arg580 is rotated by almost 180° toward BcsA's GT domain, and it forms a salt bridge with Glu371 (ref. 27 ). This interaction is broken upon c-di-GMP binding, thus leading to increased flexibility of BcsA's gating loop as described below.
The nonconserved Arg579, directly preceding the RXXXR motif, runs coplanar to the guanine group of c-di-GMP-B and stacks on top of c-di-GMP-A (Supplementary Fig. 2b) . A basic residue in this position is probably necessary to stabilize the interaction with a c-di-GMP dimer, as demonstrated by mutagenesis studies on isolated PilZ domains 16, 34 .
Most structures of β-barrel-containing PilZ domains contain a short α-helix that follows the last strand of the β-barrel and lies flat npg a r t i c l e s across its opening 16, 17 . In BcsA, this helix (termed the 'hinge helix') is sandwiched at the interface between the β-barrel and the GT domain (Fig. 1b) . When the β-barrel interacts with c-di-GMP, it rotates by approximately 20° around the hinge helix toward the GT domain (Fig. 1b) . This rotation closes a groove between the β-barrel and the GT domain that accommodates a short stretch of BcsA's nonconserved extreme C terminus in the c-di-GMP-free state 27 , thus leading to the disorder of BcsA's C-terminal residues past Arg740.
Conformational changes of the gating loop
C-di-GMP binding allows BcsA's conserved gating loop (residues 499-517) to adopt a new conformation, away from the active site cleft and near the water-lipid interface ( Fig. 2a and Supplementary  Fig. 3 ).
In this 'open' state, the gating loop is stabilized by hydrophobic interactions with BcsA's amphipathic interface helices (IF), which run parallel to the plane of the membrane at the cytosolic waterlipid boundary (Figs. 1 and 2a) and form the entrance to BcsA's TM channel 27 . Phe503 and Val505 of the gating loop's FXVTXK motif ( Supplementary Fig. 3a ) pack into a conserved hydrophobic pocket formed by Ile377 of IF2, Tyr486, Leu487 and Ala490 of IF3 and Ile520 at the beginning of TM helix 7 (Fig. 2a) .
The transition of the gating loop from the previously observed resting state to the open state is supported by c-di-GMP-induced conformational changes of the PilZ domain. In the absence of c-di-GMP, the gating loop rests in front of the GT-domain entrance, thereby blocking the active site ( Fig. 2 and Supplementary Fig. 3 ). This resting state is stabilized by Arg580, within the PilZ domain's RXXXR motif, which contacts the backbone carbonyl of Thr511 near the C-terminal end of the gating loop (Fig. 3) . This position of Arg580 is further stabilized by its formation of a salt bridge with Glu371 of the GT domain (Fig. 3) . The gating loop further interacts with the PilZ domain via its C-terminal end, which forms a two-stranded β-sheet with the cdi-GMP-binding TM8-β-barrel linker (Fig. 1) . Accordingly, in the presence of c-di-GMP, the TM8-β-barrel linker together with the interacting gating loop rotates by about 2 Å toward the water-lipid interface (Fig. 1b) , and, importantly, Arg580 rotates by 180° away from the GT domain to coordinate c-di-GMP, thereby breaking its interaction with the gating loop and Glu371 (Fig. 3) . This transition releases the gating loop, allowing it to pivot around Arg499 and Glu514 and to swing from its resting state toward the membrane interface. The movement of the gating loop, particularly residues 504-510, creates a large window at the GT-domain entrance approximately 22.5 Å by 12.5 Å wide, a size sufficient to allow UDP-Glc to enter and UDP to exit the active site (Fig. 2b) .
In order to mimic a substrate-bound state of BcsA, we soaked crystals with UDP, a product and competitive inhibitor of BcsA 23 . In the presence of UDP, the gating loop is found in another conformation in which it is inserted deep into the substrate-binding pocket ( Fig. 4a and Supplementary Fig. 3c,d ). The loop swings by approximately 15 Å toward the active site, thereby closing the large window formed in its open conformation ( Fig. 4a and Supplementary Fig. 3e ). In this 'inserted' state, each residue of the loop's FXVTXK motif is npg a r t i c l e s involved in coordinating UDP at the active site. Phe503 and Val505 rest on opposing sides above the uracil moiety while Thr506 and Lys508 coordinate the UDP pyrophosphate (Fig. 4b) . The pyrophosphate is further stabilized by Gln379 and Arg382 of the QXXRW motif as well as by a Mg 2+ ion coordinated in turn by Asp246 and Asp248 of the DXD motif and His249. Thus, the insertion of the gating loop is likely to be important for positioning the donor for catalysis. Indeed, in the absence of c-di-GMP, loop insertion into the active site is prevented, owing to steric clashes of the loop's backbone with the Arg580-Glu371 salt bridge (Supplementary Fig. 4b) , thus further ensuring a catalytically inactive state.
C-di-GMP releases an autoinhibited state of BcsA
Activation by c-di-GMP is a characteristic of prokaryotic cellulose synthases 10, 35 . Arg580 within the TM8-β-barrel linker either interacts with c-di-GMP or, in the absence of the allosteric activator, points toward the GT domain by forming a salt bridge with Glu371, thereby tethering the gating loop in the resting position (Fig. 3) . Although belonging to the evolutionarily conserved GT domain, Glu371 is conserved only among prokaryotic, c-di-GMP-responsive cellulose synthases, thus suggesting a regulatory function for the Arg580-Glu371 interaction (Supplementary Fig. 4a) .
Indeed, disrupting this salt bridge by replacing Glu371 with alanine increases the enzyme's catalytic activity in the absence of c-di-GMP approximately six-fold compared to the activity of the wild-type enzyme (Fig. 5a,b) . Under these conditions, Arg580 may still be able to interact with the gating loop's backbone. However, replacing Arg580 with alanine, either on the wild-type or E371A background, renders BcsA constitutively active, as observed by quantifying the formation of each reaction product: cellulose (Fig. 5a,b and Supplementary  Fig. 5a ) or UDP (Fig. 5c) . Importantly, the R580A mutant still binds c-di-GMP, although with slightly reduced affinity ( Supplementary  Fig. 5b ); yet, even at a c-di-GMP concentration more than 50-fold above its dissociation constant, we observed no further stimulation of cellulose biosynthesis (Fig. 5d) . These observations suggest that the Arg580-Glu371 salt bridge and the subsequent interaction of Arg580 with the gating loop are responsible for autoinhibiting the synthase. This inhibition is then released when Arg580 rotates away from the GT domain to interact with c-di-GMP.
The TM-channel entrance forms the acceptor-binding site After sugar transfer, processive GTs, including cellulose, chitin, alginate and hyaluronan synthases, must translocate the elongated polysaccharide so that the newly formed product sits in a position where it can serve as the acceptor in a subsequent glycosyl transfer reaction. BcsA contacts the acceptor end of the translocating cellulose polymer via a finger helix that belongs to the conserved GT domain (Fig. 1) . The finger helix contains the TED motif at its N terminus, of which Asp343 probably forms the general base for catalysis 27 . In contrast to our previously reported structure in which the finger helix points away from the TM-channel entrance ('down' state) 27 , this helix is bent toward the entrance to the channel in both of our new structures, and the cellulose polymer is moved into the channel by one glucose unit (Fig. 6a) . The finger helix bends near its last C-terminal helical turn and around the conserved His351 (Supplementary Fig. 6a ), (Supplementary Fig. 6b ).
Asp343 at the tip of the finger helix moves by approximately 5 Å toward the TM-channel entrance, a distance in agreement with the length of a glucopyranose unit (Fig. 6a,b) . A network of conserved hydrophilic and hydrophobic interactions stabilizes the 'up' position of the finger helix near the TM-channel entrance, including residues from the gating loop, IF2 and the TM channel. Phe316 and Phe317 of the FFCGS motif ( Supplementary  Fig. 7 ) at the TM-channel entrance straddle the helix, and additional van der Waals interactions are mediated via Gly386 and Met390 of IF2 and Tyr410 within the N-terminal amphipathic section of TM helix 5 ( Fig. 6c and Supplementary Fig. 6b ). In addition, Thr339, preceding the TED motif of the finger helix, hydrogen-bonds with the conserved Gln389 of IF2, which in turn interacts with Pro498 at the N-terminal end of the gating loop (Fig. 6c) .
The movement of the finger helix toward the channel entrance is supported by a small peripheral loop (residues 333-338) that precedes the finger helix. The loop carries a conserved glycine residue (Gly334) at its midpoint, which is followed by a bulky hydrophobic residue, usually phenylalanine or isoleucine (Fig. 6a,c and Supplementary Fig. 6a ).
In the c-di-GMP-bound state, the loop moves toward the GT domain, and Phe335 'plugs' into a conserved hydrophobic pocket beneath the active site, where it is surrounded by the side chains of Met230, Leu234, Val244, Phe317, Leu324 and Leu329 ( Fig. 6c and  Supplementary Fig. 6c ).
The position of the translocating glucan's terminal glucose unit in the c-di-GMP-bound BcsA-BcsB complex suggests that the acceptor coordination site is located just inside the entrance to the TM channel (Fig. 6a,d) . One face of the acceptor's glucopyranose ring forms CH-π stacking interactions 36 with Trp383 of the QXXRW motif, which is characteristic of processive GTs, while its opposite side contacts the carbonyl oxygen of Cys318 of the FFCGS motif ( Fig. 6c  and Supplementary Fig. 7 ). The N-terminal part of the finger helix contacts the acceptor via the TED motif, whose Thr341 and Asp343 form hydrogen bonds with the acceptor's 2′-or 6′-(depending on its orientation) and 4′-OH groups (Fig. 6c,d ). In particular, the side chain carboxylate of Asp343 is within 2.6 Å of the acceptor's 4′-OH group, in agreement with its putative role as the catalytic base during glycosyl transfer 27 . The acceptor further interacts with Tyr302, also located at the entrance to the TM channel (Fig. 6d) . Accordingly, this implies that cellulose synthase forms the acceptor coordination site Fig. 7) . The stabilization of the terminal glucose unit at this position resembles the coordination of a single galactose molecule in the sodium-coupled sugar transporter vSGLT 37 (Fig. 6e) , thus suggesting that BcsA's acceptor-binding site might also suffice to coordinate a single glucose molecule as a primer to initiate cellulose synthesis.
DISCUSSION
Comparing the structures of the c-di-GMP-activated and resting conformations of the BcsA-BcsB complex at intermediate states during cellulose translocation provides unique insights into the mechanism of cellulose biosynthesis. In the absence of c-di-GMP, BcsA is catalytically inactive, and its gating loop blocks the entrance to the active site 23, 27 . Allosteric activation by c-di-GMP displaces the gating loop from the active site, thereby forming a large entrance to the substratebinding pocket, which is wide enough for substrate diffusion. However, opening and closing of the active site is unlikely to be the only function of BcsA's gating loop. When UDP binds to the active site, the gating loop inserts deeply into the catalytic pocket and coordinates the nucleotide via conserved residues. This probably also reflects how BcsA interacts with its substrate UDP-Glc, to position it for catalysis, exclude water from the active site and perhaps also stabilize the UDP leaving group during glycosyl transfer. A similar mechanism of substrate-dependent loop insertion and deinsertion has been described for nonprocessive galactosyltransferases 38, 39 .
The functional importance of the gating loop is further underlined by its sequence homology with the location of the isoxaben-resistance mutation in Arabidopsis thaliana cellulose synthase 3 ( Supplementary  Fig. 3a) . Here, Thr942 of the FXVTXK motif is mutated to isoleucine, thereby allowing growth in the presence of the herbicide isoxaben 40 . However, because pro-and eukaryotic cellulose synthases differ in their predicted TM topologies 28 , further experimental analyses are required to confirm a similar eukaryotic gating-loop function.
UDP, the second reaction product of many GTs 24, 41 , competitively inhibits BcsA; this inhibition has also been observed for hyaluronan synthases 23, 42 . BcsA binds UDP and UDP-Glc with similar affinities 23 ; however, the large excess of UDP-Glc over UDP under physiological conditions would favor substrate binding upon gating-loop opening 43 . Presumably, during or after UDP-Glc binding, the gating loop inserts into the active site to initiate catalysis. After glycosyl transfer and with the newly extended glucan at the active site, the gating loop may retract from the GT domain, thereby allowing UDP to exchange with UDP-Glc. Because the gating loop undergoes its full range of motion in the presence of c-di-GMP, it is likely that the allosteric activator remains bound during catalysis. In vivo, c-di-GMP-stimulated cellulose biosynthesis may terminate upon depletion of the activator, whose cytosolic concentration is in turn controlled by the activities of diguanylate cyclases and diesterases 1 .
The BcsA-BcsB complex contains a translocating cellulose polymer that spans the distance from the GT domain to the periplasmic BcsABcsB interface. In the c-di-GMP-activated structure, the polymer's a r t i c l e s acceptor terminus rests at the entrance to the TM channel, one glucose unit further into the pore as compared to its position in the absence of c-di-GMP 27 . Thus, whereas our previously reported structure probably represents a state after glycosyl transfer but before translocation, the c-di-GMP-activated BcsA-BcsB structure is consistent with a state after polymer translocation. Cellulose translocation may be accomplished by BcsA's finger helix, which hydrogen-bonds with the acceptor glucose and pivots toward the TM-channel entrance in the c-di-GMP-activated complex. In this position, Asp343 of the finger helix is at an ideal distance to facilitate catalysis. Perhaps the finger helix returns to the down position after glycosyl transfer to interact with the new polymer terminus. A similar mechanism involving a flexible loop or helical domain has been postulated for the processive translocation of unfolded polypeptide chains 44, 45 .
C-di-GMP stimulates the biosynthesis of several extracellular polysaccharides important for biofilm formation, including alginate and PNAG [46] [47] [48] . Although the mechanism for activating PNAG biosynthesis probably differs from the mechanism of BcsA 48 , alginate and cellulose synthases share a strikingly similar organization 49 . Alginate is a major component of Pseudomonas aeruginosa biofilms in the respiratory tracts of patients with cystic fibrosis 7, 18 . In contrast to BcsA-BcsB, the alginate synthase's c-di-GMP-binding PilZ domain is located at the intracellular N terminus of Alg44, the noncatalytic subunit that resembles BcsB and probably interacts with the catalytic Alg8 subunit 18 . Thus, c-di-GMP could exert control by a similar mechanism in alginate synthase as revealed for bacterial cellulose synthase.
Our analyses provide the first mechanistic insights, to our knowledge, into how enzymatic functions can be modulated by c-di-GMP. A detailed mechanistic characterization of this bacterial signaling system is required for the development of new antimicrobial therapeutics.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Protein purification. BcsA-BcsB was purified as previously described 27 with the exception that gel filtration was carried out in 20 mM Tris, pH 7.5, 100 mM NaCl, 5 mM MgCl 2 , 5 mM cellobiose, 10% glycerol, 5 mM N,N-dimethyl-N-dodecylamine N-oxide (LDAO) and 0.3 mM LysoFosCholine Ether 12 (LFCE12), (GF buffer). Peak fractions containing BcsA and BcsB were collected and concentrated to ~10 mg/ml and spun at 180,000g for 15 min at 4 °C. Bicelles were prepared by mixture of 250 µl water with 100 mg of 1,2-dimyristoyl-sn-glycero-3-phosphocholine:1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine:3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, (DMPC/POPE/CHAPS) at a molar ratio of ~2.34:0.05:1. The concentrated protein was mixed with the bicelles at a 4:1 (v/v) ratio and allowed to equilibrate on ice for at least 1 h. 2 mM UDP and 1 mM c-di-GMP were added before incubation on ice overnight.
Crystallization. Crystals belonging to space group P2 1 2 1 2 1 were grown by sitting-drop vapor diffusion at 30 °C in 1.6-1.9 M sodium acetate and 100 mM sodium citrate, pH 3-3.5, (final pH ≈ 5.6) at a 1:1 (v/v) ratio of protein/bicelle to well solution. Crystals appeared within 3 d and reached their final size within 14 d. For the UDP-free structure, cryoprotection and dilution of UDP were achieved by gradual addition of a solution containing 20 mM sodium citrate, pH 3, 100 mM NaCl, 5 mM MgCl 2 , 1.95 M sodium acetate, 20% glycerol, and 20% bicelles to the drop. For the UDP-bound structure, cryoprotection and soaking with UDP were achieved by gradual addition of a solution containing 20 mM sodium citrate, pH 3.5, 50 mM MgCl 2 , 1.95 M sodium acetate, 20% glycerol, 12% bicelles, and 10 mM UDP to the drop. Crystals were flash-cooled in liquid nitrogen for data collection.
Data collection and processing. Diffraction data were collected at 100 K at a wavelength of 1.0 Å. Data in the absence of UDP were collected at the Advanced Photon Source SER-CAT beamline 22-ID, and data in the presence of UDP were collected at GM/CA-CAT beamline 23-ID. The data were integrated with Mosflm 51 and scaled in Aimless as part of the CCP4 program suite 52 .
Structure determination. Initial phases for the UDP-free structure were determined by molecular replacement (MR) in Phaser 53 with a search model of ligandfree BcsA-BcsB (PDB 4HG6 (ref. 27)) with BcsA residues 499-512 (gating loop) and 574-758 (C terminus) truncated. MR phases for the UDP-bound structure were determined in MOLREP 54 , with the UDP-free structure without the gating loop as a search model. The models were refined by rigid-body and restrained refinement in Refmac5 (ref. 52) as well as by simulated annealing in Phenix 55 . Phases were improved with density modification in Parrot 56, 57 , and model building was performed in Coot 58 . Iterative rounds of model building, refinement, and density modification resulted in a map of sufficient quality to place the missing domains and ligands. In order to minimize model bias, simulated annealing composite omit maps, prime and switch maps, and kicked maps 55, 59 were calculated and evaluated throughout the model-building process. Additionally, TLS parameters determined from the TLSMD server 60 were used in later rounds of refinement. The model contains residues 13-740 of BcsA and residues 54-720 of BcsB. Residues 532-543 of BcsB are disordered, as was previously observed 27 , and were omitted from the model. A ten-residue-long unidentified peptide probably belonging to either the extended N terminus of BcsB or the C terminus of BcsA is sandwiched by BcsB's flavodoxin-like domain 2 and carbohydrate-binding domain 2 (ref. 27 ) between crystallographic symmetry mates. This peptide was modeled as a polyalanine with chain identifier 'D' . The UDP-free model contains five partially ordered lipids, one modeled as 1,2-diacyl-sn-glycero-3-phosphoethanolamine and four modeled as 1,2-diacyl-sn-glycero-3-phosphocholine. Two of these lipids were also observed in the UDP-bound structure.
The UDP-free BcsA-BcsB structure was refined to an R/R free of 19.9/23.0. 95.8% of residues lie in the favored regions of the Ramachandran plot, with no outliers. The structure of the UDP-bound complex was refined to an R/R free of 20.6/23.8. 95.1% of residues lie in the favored region on a Ramachandran plot, with 0.7% outliers. Figures were prepared in PyMOL (http://www.pymol.org/) and the analysis of solvent accessible surface was performed in HOLLOW 61 . Crystallographic software support is provided by SBGrid 62 .
Preparation of inverted membrane vesicles. Inverted membrane vesicles (IMVs) containing wild-type BcsB and the indicated BcsA mutants were prepared as previously described 30 . Control IMVs were prepared from E. coli transformed with an empty pETDuet vector. In brief, the constructs were expressed as described 27 , and the cells were resuspended in RB buffer containing 20 mM sodium phosphate, pH 7.3, 100 mM NaCl, and 10% glycerol with 20 ml RB per cell pellet from a 1-l culture. The cells were lysed in a microfluidizer and spun at 12,000g for 20 min to clear the cell debris. The supernatant was applied on the surface of a 1.8-M sucrose cushion and spun at 150,000g for 2 h at 4 °C. IMVs were harvested, diluted three-fold in RB, and spun at 150,000g overnight. The pellet from a 3-l culture was resuspended in 1 ml RB, homogenized in a dounce homogenizer and stored in aliquots at −80 °C.
Proteoliposome preparation. Purified BcsA-BcsB complex containing the indicated mutations were reconstituted into proteoliposomes (PLs) as previously described 23 . Briefly, BcsA-BcsB was purified as described above with the exception that 1 mM LysoFosCholine Ether 14 (LFCE14) was used instead of LDAO. The protein was concentrated to 5 µM, incubated with 4 mg/ml E. coli total lipid extract (diluted from a 20 mg/ml stock solution in 40 mM LDAO) and allowed to equilibrate on ice for at least 20 min. Bio-Beads (Bio-Rad) were added, and the solution was rotated until it became turbid, thus indicating the formation of PLs. The samples were then divided into aliquots, snap frozen in liquid nitrogen, and stored at −80 °C. The final protein concentration for all mutants was determined by UV absorbance and SDS-PAGE with subsequent Coomassie staining.
In vitro cellulose synthesis assay. IMVs or PLs were added to a solution containing 20 mM sodium phosphate, 100 mM NaCl, 20 mM MgCl 2 , 5 mM UDPglucose, 12.5 µCi/ml UDP-[ 3 H]glucose as well as 30 µM c-di-GMP unless indicated otherwise. The reaction was incubated at 37 °C for 45 min with shaking at 350 r.p.m. 2% SDS was added to terminate the reaction and dissolve the vesicles. The mixture was then spun at 21,000g for at least 20 min to pellet the insoluble cellulose. The supernatant was carefully removed, and the pellet was resuspended in 50 mM Tris, pH 7.5, and 100 mM NaCl and spotted on Whatman 3-mm grid paper. The product was purified in 60% ethanol by descending paper chromatography, with the insoluble cellulose remaining at the origin, and quantified by scintillation counting 30 . All measurements were performed at least in triplicate, and error bars represent s.d.
Western analysis. 10 µL IMVs were analyzed by SDS-PAGE and transferred to a nitrocellulose membrane with a Bio-Rad Mini-Transfer Cell according to the manufacturer's specifications. The nitrocellulose membrane was blocked in 5% milk/TBS-Tween solution for 30 min and incubated overnight with a mouse anti-His 5 (Qiagen) antibody. The membranes were washed three times in 5% milk/TBS-Tween before incubation with an IRDye800-conjugated anti-mouse secondary antibody (Rockland) for 45 min at RT. After being washed, the membranes were scanned on an Odyssey Infrared Imager (Licor). All antibodies were validated by the manufacturer and diluted according to the manufacturer's specifications.
Enzyme-coupled activity assay. Enzyme-coupled kinetic assays were carried out as previously described 23 with the exceptions that the protein was reconstituted into PLs instead of nanodiscs, the experiments were performed in 150-µl reaction volume in 96-well flat-bottom Microplates (Greiner), and 3 mM UDP-Glc was used.
Isothermal titration calorimetry. The protein was purified in 1 mM LFCE14 as described above. Measurements were carried out at 25 °C in a MicroCal iTC200 system (GE Healthcare) with 250 µl of BcsA-BcsB in the cell at 9.3 µM for WT and 11 µM for the BcsA R580A complex and 400 µM c-di-GMP in the syringe. An initial 0.5-µl injection was followed by 39 1-µl injections spaced 180 s apart with stirring at 700 r.p.m. The data were fit with Origin 7.0 as provided by the manufacturer. 
